Jennifer Liu

Davis Polk advised Shenzhen Hepalink Pharmaceutical Group Co., Ltd. in connection with its initial public offering and listing on the Hong Kong Stock Exchange and an international offering…

Davis Polk advised the joint lead managers in connection with the debut offering of $300 million 2.125% bonds due 2025 issued by New Oriental Education & Technology Group Inc. New…

Davis Polk advised the initial purchasers on the Regulation S offering of high-yield notes by Ronshine China Holdings Limited of $250 million principal amount of 7.350% senior notes due…

Davis Polk advised Tencent Holdings Limited as English and U.S. law counsel in connection with the update of its $20 billion global medium-term note program and the offering thereunder…

Davis Polk advised the dealer manager in connection with a cash tender offer by Envision Energy International Limited for its outstanding 7.500% senior notes due 2021. Established in 2007…

Davis Polk advised Tianfeng Securities Co., Ltd. in connection with its $100 million notes offering. The notes will be consolidated and form a single series with the $200 million notes…

Davis Polk advised the dealers in connection with the establishment of $2 billion medium-term note program by China Cinda (2020) I Management Limited which is a wholly owned subsidiary of…

Davis Polk advised the joint lead managers in connection with the Regulation S offering of $110 million principal amount of 12.5% senior notes due 2022 by Yango (Cayman) Investment Limited…

Davis Polk advised Venus Medtech (Hangzhou) Inc. in connection with its initial public offering and listing on the Hong Kong Stock Exchange and an international offering in reliance on Rule…

Davis Polk advised the joint lead managers in connection with the Regulation S only offering by Gaoxin International Investment Co., Ltd. of its $100 million 6.00% guaranteed bonds due 2022…